Sepsis is an unusual systemic reaction to what is sometimes an otherwise ordinary infection, and it probably represents a pattern of response by the immune system to injury.

Fully considering the economic change by this health crisis, Blood Biomarkers accounting for % of the Sepsis Biomarkers global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Diagnostics segment is altered to an % CAGR throughout this forecast period.

China Sepsis Biomarkers market size is valued at US$ million in 2021, while the North America and Europe Sepsis Biomarkers are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period.

As for the Europe Sepsis Biomarkers landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Sepsis Biomarkers market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Sepsis Biomarkers market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Sepsis Biomarkers market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Sepsis Biomarkers market.

Sepsis Biomarkers Scope and Market Size

Sepsis Biomarkers market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Sepsis Biomarkers market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Blood Biomarkers
Urine Biomarkers

Segment by Application

Diagnostics
Drug Discovery
Personalized Medicine
Others

BY COMPANY

Thermo Fisher Scientific
Merck
Bio-Rad Laboratories
QIAGEN
Roche
Danaher Corporation
Siemens Healthcare
Abbott
GenMark Diagnostics
HiMedia Laboratories
Immunexpress
Abionic
T2 Biosystems

BY REGION

North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

1 Report Business Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Sepsis Biomarkers Market Size Growth Rate by Type, 2017 VS 2021 VS 2028

1.2.2 Blood Biomarkers

1.2.3 Urine Biomarkers

1.3 Market by Application

1.3.1 Global Sepsis Biomarkers Market Size Growth Rate by Application, 2017 VS 2021 VS 2028

1.3.2 Diagnostics

1.3.3 Drug Discovery

1.3.4 Personalized Medicine

1.3.5 Others

1.4 Study Objectives

1.5 Years Considered

2 Global Growth Trends

2.1 Global Sepsis Biomarkers Market Perspective (2017-2028)

2.2 Sepsis Biomarkers Growth Trends by Region

2.2.1 Sepsis Biomarkers Market Size by Region: 2017 VS 2021 VS 2028

2.2.2 Sepsis Biomarkers Historic Market Size by Region (2017-2022)

2.2.3 Sepsis Biomarkers Forecasted Market Size by Region (2023-2028)

2.3 Sepsis Biomarkers Market Dynamics

2.3.1 Sepsis Biomarkers Industry Trends

2.3.2 Sepsis Biomarkers Market Drivers

2.3.3 Sepsis Biomarkers Market Challenges

2.3.4 Sepsis Biomarkers Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Sepsis Biomarkers Players by Revenue

3.1.1 Global Top Sepsis Biomarkers Players by Revenue (2017-2022)

3.1.2 Global Sepsis Biomarkers Revenue Market Share by Players (2017-2022)

3.2 Global Sepsis Biomarkers Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Sepsis Biomarkers Revenue

3.4 Global Sepsis Biomarkers Market Concentration Ratio

3.4.1 Global Sepsis Biomarkers Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Sepsis Biomarkers Revenue in 2021

3.5 Sepsis Biomarkers Key Players Head office and Area Served

3.6 Key Players Sepsis Biomarkers Product Solution and Service

3.7 Date of Enter into Sepsis Biomarkers Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Sepsis Biomarkers Breakdown Data by Type

4.1 Global Sepsis Biomarkers Historic Market Size by Type (2017-2022)

4.2 Global Sepsis Biomarkers Forecasted Market Size by Type (2023-2028)

5 Sepsis Biomarkers Breakdown Data by Application

5.1 Global Sepsis Biomarkers Historic Market Size by Application (2017-2022)

5.2 Global Sepsis Biomarkers Forecasted Market Size by Application (2023-2028)

6 North America

6.1 North America Sepsis Biomarkers Market Size (2017-2028)

6.2 North America Sepsis Biomarkers Market Size by Type

6.2.1 North America Sepsis Biomarkers Market Size by Type (2017-2022)

6.2.2 North America Sepsis Biomarkers Market Size by Type (2023-2028)

6.2.3 North America Sepsis Biomarkers Market Share by Type (2017-2028)

6.3 North America Sepsis Biomarkers Market Size by Application

6.3.1 North America Sepsis Biomarkers Market Size by Application (2017-2022)

6.3.2 North America Sepsis Biomarkers Market Size by Application (2023-2028)

6.3.3 North America Sepsis Biomarkers Market Share by Application (2017-2028)

6.4 North America Sepsis Biomarkers Market Size by Country

6.4.1 North America Sepsis Biomarkers Market Size by Country (2017-2022)

6.4.2 North America Sepsis Biomarkers Market Size by Country (2023-2028)

6.4.3 U.S.

6.4.4 Canada

7 Europe

7.1 Europe Sepsis Biomarkers Market Size (2017-2028)

7.2 Europe Sepsis Biomarkers Market Size by Type

7.2.1 Europe Sepsis Biomarkers Market Size by Type (2017-2022)

7.2.2 Europe Sepsis Biomarkers Market Size by Type (2023-2028)

7.2.3 Europe Sepsis Biomarkers Market Share by Type (2017-2028)

7.3 Europe Sepsis Biomarkers Market Size by Application

7.3.1 Europe Sepsis Biomarkers Market Size by Application (2017-2022)

7.3.2 Europe Sepsis Biomarkers Market Size by Application (2023-2028)

7.3.3 Europe Sepsis Biomarkers Market Share by Application (2017-2028)

7.4 Europe Sepsis Biomarkers Market Size by Country

7.4.1 Europe Sepsis Biomarkers Market Size by Country (2017-2022)

7.4.2 Europe Sepsis Biomarkers Market Size by Country (2023-2028)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

7.4.8 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Sepsis Biomarkers Market Size (2017-2028)

8.2 Asia-Pacific Sepsis Biomarkers Market Size by Type

8.2.1 Asia-Pacific Sepsis Biomarkers Market Size by Type (2017-2022)

8.2.2 Asia-Pacific Sepsis Biomarkers Market Size by Type (2023-2028)

8.2.3 Asia-Pacific Sepsis Biomarkers Market Share by Type (2017-2028)

8.3 Asia-Pacific Sepsis Biomarkers Market Size by Application

8.3.1 Asia-Pacific Sepsis Biomarkers Market Size by Application (2017-2022)

8.3.2 Asia-Pacific Sepsis Biomarkers Market Size by Application (2023-2028)

8.3.3 Asia-Pacific Sepsis Biomarkers Market Share by Application (2017-2028)

8.4 Asia-Pacific Sepsis Biomarkers Market Size by Region

8.4.1 Asia-Pacific Sepsis Biomarkers Market Size by Region (2017-2022)

8.4.2 Asia-Pacific Sepsis Biomarkers Market Size by Region (2023-2028)

8.4.3 China

8.4.4 Japan

8.4.5 South Korea

8.4.6 Southeast Asia

8.4.7 India

8.4.8 Australia

9 Latin America

9.1 Latin America Sepsis Biomarkers Market Size (2017-2028)

9.2 Latin America Sepsis Biomarkers Market Size by Type

9.2.1 Latin America Sepsis Biomarkers Market Size by Type (2017-2022)

9.2.2 Latin America Sepsis Biomarkers Market Size by Type (2023-2028)

9.2.3 Latin America Sepsis Biomarkers Market Share by Type (2017-2028)

9.3 Latin America Sepsis Biomarkers Market Size by Application

9.3.1 Latin America Sepsis Biomarkers Market Size by Application (2017-2022)

9.3.2 Latin America Sepsis Biomarkers Market Size by Application (2023-2028)

9.3.3 Latin America Sepsis Biomarkers Market Share by Application (2017-2028)

9.4 Latin America Sepsis Biomarkers Market Size by Country

9.4.1 Latin America Sepsis Biomarkers Market Size by Country (2017-2022)

9.4.2 Latin America Sepsis Biomarkers Market Size by Country (2023-2028)

9.4.3 Mexico

9.4.4 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Sepsis Biomarkers Market Size (2017-2028)

10.2 Middle East & Africa Sepsis Biomarkers Market Size by Type

10.2.1 Middle East & Africa Sepsis Biomarkers Market Size by Type (2017-2022)

10.2.2 Middle East & Africa Sepsis Biomarkers Market Size by Type (2023-2028)

10.2.3 Middle East & Africa Sepsis Biomarkers Market Share by Type (2017-2028)

10.3 Middle East & Africa Sepsis Biomarkers Market Size by Application

10.3.1 Middle East & Africa Sepsis Biomarkers Market Size by Application (2017-2022)

10.3.2 Middle East & Africa Sepsis Biomarkers Market Size by Application (2023-2028)

10.3.3 Middle East & Africa Sepsis Biomarkers Market Share by Application (2017-2028)

10.4 Middle East & Africa Sepsis Biomarkers Market Size by Country

10.4.1 Middle East & Africa Sepsis Biomarkers Market Size by Country (2017-2022)

10.4.2 Middle East & Africa Sepsis Biomarkers Market Size by Country (2023-2028)

10.4.3 Turkey

10.4.4 Saudi Arabia

10.4.5 UAE

11 Key Players Profiles

11.1 Thermo Fisher Scientific

11.1.1 Thermo Fisher Scientific Company Details

11.1.2 Thermo Fisher Scientific Business Overview

11.1.3 Thermo Fisher Scientific Sepsis Biomarkers Introduction

11.1.4 Thermo Fisher Scientific Revenue in Sepsis Biomarkers Business (2017-2022)

11.1.5 Thermo Fisher Scientific Recent Developments

11.2 Merck

11.2.1 Merck Company Details

11.2.2 Merck Business Overview

11.2.3 Merck Sepsis Biomarkers Introduction

11.2.4 Merck Revenue in Sepsis Biomarkers Business (2017-2022)

11.2.5 Merck Recent Developments

11.3 Bio-Rad Laboratories

11.3.1 Bio-Rad Laboratories Company Details

11.3.2 Bio-Rad Laboratories Business Overview

11.3.3 Bio-Rad Laboratories Sepsis Biomarkers Introduction

11.3.4 Bio-Rad Laboratories Revenue in Sepsis Biomarkers Business (2017-2022)

11.3.5 Bio-Rad Laboratories Recent Developments

11.4 QIAGEN

11.4.1 QIAGEN Company Details

11.4.2 QIAGEN Business Overview

11.4.3 QIAGEN Sepsis Biomarkers Introduction

11.4.4 QIAGEN Revenue in Sepsis Biomarkers Business (2017-2022)

11.4.5 QIAGEN Recent Developments

11.5 Roche

11.5.1 Roche Company Details

11.5.2 Roche Business Overview

11.5.3 Roche Sepsis Biomarkers Introduction

11.5.4 Roche Revenue in Sepsis Biomarkers Business (2017-2022)

11.5.5 Roche Recent Developments

11.6 Danaher Corporation

11.6.1 Danaher Corporation Company Details

11.6.2 Danaher Corporation Business Overview

11.6.3 Danaher Corporation Sepsis Biomarkers Introduction

11.6.4 Danaher Corporation Revenue in Sepsis Biomarkers Business (2017-2022)

11.6.5 Danaher Corporation Recent Developments

11.7 Siemens Healthcare

11.7.1 Siemens Healthcare Company Details

11.7.2 Siemens Healthcare Business Overview

11.7.3 Siemens Healthcare Sepsis Biomarkers Introduction

11.7.4 Siemens Healthcare Revenue in Sepsis Biomarkers Business (2017-2022)

11.7.5 Siemens Healthcare Recent Developments

11.8 Abbott

11.8.1 Abbott Company Details

11.8.2 Abbott Business Overview

11.8.3 Abbott Sepsis Biomarkers Introduction

11.8.4 Abbott Revenue in Sepsis Biomarkers Business (2017-2022)

11.8.5 Abbott Recent Developments

11.9 GenMark Diagnostics

11.9.1 GenMark Diagnostics Company Details

11.9.2 GenMark Diagnostics Business Overview

11.9.3 GenMark Diagnostics Sepsis Biomarkers Introduction

11.9.4 GenMark Diagnostics Revenue in Sepsis Biomarkers Business (2017-2022)

11.9.5 GenMark Diagnostics Recent Developments

11.10 HiMedia Laboratories

11.10.1 HiMedia Laboratories Company Details

11.10.2 HiMedia Laboratories Business Overview

11.10.3 HiMedia Laboratories Sepsis Biomarkers Introduction

11.10.4 HiMedia Laboratories Revenue in Sepsis Biomarkers Business (2017-2022)

11.10.5 HiMedia Laboratories Recent Developments

11.11 Immunexpress

11.11.1 Immunexpress Company Details

11.11.2 Immunexpress Business Overview

11.11.3 Immunexpress Sepsis Biomarkers Introduction

11.11.4 Immunexpress Revenue in Sepsis Biomarkers Business (2017-2022)

11.11.5 Immunexpress Recent Developments

11.12 Abionic

11.12.1 Abionic Company Details

11.12.2 Abionic Business Overview

11.12.3 Abionic Sepsis Biomarkers Introduction

11.12.4 Abionic Revenue in Sepsis Biomarkers Business (2017-2022)

11.12.5 Abionic Recent Developments

11.13 T2 Biosystems

11.13.1 T2 Biosystems Company Details

11.13.2 T2 Biosystems Business Overview

11.13.3 T2 Biosystems Sepsis Biomarkers Introduction

11.13.4 T2 Biosystems Revenue in Sepsis Biomarkers Business (2017-2022)

11.13.5 T2 Biosystems Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Thermo Fisher Scientific

List of Tables

Table 1. Global Sepsis Biomarkers Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028

Table 2. Key Players of Blood Biomarkers

Table 3. Key Players of Urine Biomarkers

Table 4. Global Sepsis Biomarkers Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028

Table 5. Global Sepsis Biomarkers Market Size by Region (US$ Million): 2017 VS 2021 VS 2028

Table 6. Global Sepsis Biomarkers Market Size by Region (2017-2022) & (US$ Million)

Table 7. Global Sepsis Biomarkers Market Share by Region (2017-2022)

Table 8. Global Sepsis Biomarkers Forecasted Market Size by Region (2023-2028) & (US$ Million)

Table 9. Global Sepsis Biomarkers Market Share by Region (2023-2028)

Table 10. Sepsis Biomarkers Market Trends

Table 11. Sepsis Biomarkers Market Drivers

Table 12. Sepsis Biomarkers Market Challenges

Table 13. Sepsis Biomarkers Market Restraints

Table 14. Global Sepsis Biomarkers Revenue by Players (2017-2022) & (US$ Million)

Table 15. Global Sepsis Biomarkers Revenue Share by Players (2017-2022)

Table 16. Global Top Sepsis Biomarkers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sepsis Biomarkers as of 2021)

Table 17. Ranking of Global Top Sepsis Biomarkers Companies by Revenue (US$ Million) in 2021

Table 18. Global 5 Largest Players Market Share by Sepsis Biomarkers Revenue (CR5 and HHI) & (2017-2022)

Table 19. Key Players Headquarters and Area Served

Table 20. Key Players Sepsis Biomarkers Product Solution and Service

Table 21. Date of Enter into Sepsis Biomarkers Market

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Sepsis Biomarkers Market Size by Type (2017-2022) & (US$ Million)

Table 24. Global Sepsis Biomarkers Revenue Market Share by Type (2017-2022)

Table 25. Global Sepsis Biomarkers Forecasted Market Size by Type (2023-2028) & (US$ Million)

Table 26. Global Sepsis Biomarkers Revenue Market Share by Type (2023-2028)

Table 27. Global Sepsis Biomarkers Market Size by Application (2017-2022) & (US$ Million)

Table 28. Global Sepsis Biomarkers Revenue Share by Application (2017-2022)

Table 29. Global Sepsis Biomarkers Forecasted Market Size by Application (2023-2028) & (US$ Million)

Table 30. Global Sepsis Biomarkers Revenue Share by Application (2023-2028)

Table 31. North America Sepsis Biomarkers Market Size by Type (2017-2022) & (US$ Million)

Table 32. North America Sepsis Biomarkers Market Size by Type (2023-2028) & (US$ Million)

Table 33. North America Sepsis Biomarkers Market Size by Application (2017-2022) & (US$ Million)

Table 34. North America Sepsis Biomarkers Market Size by Application (2023-2028) & (US$ Million)

Table 35. North America Sepsis Biomarkers Market Size by Country (2017-2022) & (US$ Million)

Table 36. North America Sepsis Biomarkers Market Size by Country (2023-2028) & (US$ Million)

Table 37. Europe Sepsis Biomarkers Market Size by Type (2017-2022) & (US$ Million)

Table 38. Europe Sepsis Biomarkers Market Size by Type (2023-2028) & (US$ Million)

Table 39. Europe Sepsis Biomarkers Market Size by Application (2017-2022) & (US$ Million)

Table 40. Europe Sepsis Biomarkers Market Size by Application (2023-2028) & (US$ Million)

Table 41. Europe Sepsis Biomarkers Market Size by Country (2017-2022) & (US$ Million)

Table 42. Europe Sepsis Biomarkers Market Size by Country (2023-2028) & (US$ Million)

Table 43. Asia Pacific Sepsis Biomarkers Market Size by Type (2017-2022) & (US$ Million)

Table 44. Asia Pacific Sepsis Biomarkers Market Size by Type (2023-2028) & (US$ Million)

Table 45. Asia Pacific Sepsis Biomarkers Market Size by Application (2017-2022) & (US$ Million)

Table 46. Asia Pacific Sepsis Biomarkers Market Size by Application (2023-2028) & (US$ Million)

Table 47. Asia Pacific Sepsis Biomarkers Market Size by Region (2017-2022) & (US$ Million)

Table 48. Asia Pacific Sepsis Biomarkers Market Size by Region (2023-2028) & (US$ Million)

Table 49. Latin America Sepsis Biomarkers Market Size by Type (2017-2022) & (US$ Million)

Table 50. Latin America Sepsis Biomarkers Market Size by Type (2023-2028) & (US$ Million)

Table 51. Latin America Sepsis Biomarkers Market Size by Application (2017-2022) & (US$ Million)

Table 52. Latin America Sepsis Biomarkers Market Size by Application (2023-2028) & (US$ Million)

Table 53. Latin America Sepsis Biomarkers Market Size by Country (2017-2022) & (US$ Million)

Table 54. Latin America Sepsis Biomarkers Market Size by Country (2023-2028) & (US$ Million)

Table 55. Middle East and Africa Sepsis Biomarkers Market Size by Type (2017-2022) & (US$ Million)

Table 56. Middle East and Africa Sepsis Biomarkers Market Size by Type (2023-2028) & (US$ Million)

Table 57. Middle East and Africa Sepsis Biomarkers Market Size by Application (2017-2022) & (US$ Million)

Table 58. Middle East and Africa Sepsis Biomarkers Market Size by Application (2023-2028) & (US$ Million)

Table 59. Middle East and Africa Sepsis Biomarkers Market Size by Country (2017-2022) & (US$ Million)

Table 60. Middle East and Africa Sepsis Biomarkers Market Size by Country (2023-2028) & (US$ Million)

Table 61. Thermo Fisher Scientific Company Details

Table 62. Thermo Fisher Scientific Business Overview

Table 63. Thermo Fisher Scientific Sepsis Biomarkers Product

Table 64. Thermo Fisher Scientific Revenue in Sepsis Biomarkers Business (2017-2022) & (US$ Million)

Table 65. Thermo Fisher Scientific Recent Developments

Table 66. Merck Company Details

Table 67. Merck Business Overview

Table 68. Merck Sepsis Biomarkers Product

Table 69. Merck Revenue in Sepsis Biomarkers Business (2017-2022) & (US$ Million)

Table 70. Merck Recent Developments

Table 71. Bio-Rad Laboratories Company Details

Table 72. Bio-Rad Laboratories Business Overview

Table 73. Bio-Rad Laboratories Sepsis Biomarkers Product

Table 74. Bio-Rad Laboratories Revenue in Sepsis Biomarkers Business (2017-2022) & (US$ Million)

Table 75. Bio-Rad Laboratories Recent Developments

Table 76. QIAGEN Company Details

Table 77. QIAGEN Business Overview

Table 78. QIAGEN Sepsis Biomarkers Product

Table 79. QIAGEN Revenue in Sepsis Biomarkers Business (2017-2022) & (US$ Million)

Table 80. QIAGEN Recent Developments

Table 81. Roche Company Details

Table 82. Roche Business Overview

Table 83. Roche Sepsis Biomarkers Product

Table 84. Roche Revenue in Sepsis Biomarkers Business (2017-2022) & (US$ Million)

Table 85. Roche Recent Developments

Table 86. Danaher Corporation Company Details

Table 87. Danaher Corporation Business Overview

Table 88. Danaher Corporation Sepsis Biomarkers Product

Table 89. Danaher Corporation Revenue in Sepsis Biomarkers Business (2017-2022) & (US$ Million)

Table 90. Danaher Corporation Recent Developments

Table 91. Siemens Healthcare Company Details

Table 92. Siemens Healthcare Business Overview

Table 93. Siemens Healthcare Sepsis Biomarkers Product

Table 94. Siemens Healthcare Revenue in Sepsis Biomarkers Business (2017-2022) & (US$ Million)

Table 95. Siemens Healthcare Recent Developments

Table 96. Abbott Company Details

Table 97. Abbott Business Overview

Table 98. Abbott Sepsis Biomarkers Product

Table 99. Abbott Revenue in Sepsis Biomarkers Business (2017-2022) & (US$ Million)

Table 100. Abbott Recent Developments

Table 101. GenMark Diagnostics Company Details

Table 102. GenMark Diagnostics Business Overview

Table 103. GenMark Diagnostics Sepsis Biomarkers Product

Table 104. GenMark Diagnostics Revenue in Sepsis Biomarkers Business (2017-2022) & (US$ Million)

Table 105. GenMark Diagnostics Recent Developments

Table 106. HiMedia Laboratories Company Details

Table 107. HiMedia Laboratories Business Overview

Table 108. HiMedia Laboratories Sepsis Biomarkers Product

Table 109. HiMedia Laboratories Revenue in Sepsis Biomarkers Business (2017-2022) & (US$ Million)

Table 110. HiMedia Laboratories Recent Developments

Table 111. Immunexpress Company Details

Table 112. Immunexpress Business Overview

Table 113. Immunexpress Sepsis Biomarkers Product

Table 114. Immunexpress Revenue in Sepsis Biomarkers Business (2017-2022) & (US$ Million)

Table 115. Immunexpress Recent Developments

Table 116. Abionic Company Details

Table 117. Abionic Business Overview

Table 118. Abionic Sepsis Biomarkers Product

Table 119. Abionic Revenue in Sepsis Biomarkers Business (2017-2022) & (US$ Million)

Table 120. Abionic Recent Developments

Table 121. T2 Biosystems Company Details

Table 122. T2 Biosystems Business Overview

Table 123. T2 Biosystems Sepsis Biomarkers Product

Table 124. T2 Biosystems Revenue in Sepsis Biomarkers Business (2017-2022) & (US$ Million)

Table 125. T2 Biosystems Recent Developments

Table 126. Research Programs/Design for This Report

Table 127. Key Data Information from Secondary Sources

Table 128. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Sepsis Biomarkers Market Share by Type: 2021 VS 2028

Figure 2. Blood Biomarkers Features

Figure 3. Urine Biomarkers Features

Figure 4. Global Sepsis Biomarkers Market Share by Application: 2021 VS 2028

Figure 5. Diagnostics Case Studies

Figure 6. Drug Discovery Case Studies

Figure 7. Personalized Medicine Case Studies

Figure 8. Others Case Studies

Figure 9. Sepsis Biomarkers Report Years Considered

Figure 10. Global Sepsis Biomarkers Market Size (US$ Million), Year-over-Year: 2017-2028

Figure 11. Global Sepsis Biomarkers Market Size, (US$ Million), 2017 VS 2021 VS 2028

Figure 12. Global Sepsis Biomarkers Market Share by Region: 2021 VS 2028

Figure 13. Global Sepsis Biomarkers Market Share by Players in 2021

Figure 14. Global Top Sepsis Biomarkers Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sepsis Biomarkers as of 2021)

Figure 15. The Top 10 and 5 Players Market Share by Sepsis Biomarkers Revenue in 2021

Figure 16. North America Sepsis Biomarkers Market Size YoY (2017-2028) & (US$ Million)

Figure 17. North America Sepsis Biomarkers Market Size Market Share by Type (2017-2028)

Figure 18. North America Sepsis Biomarkers Market Size Market Share by Application (2017-2028)

Figure 19. North America Sepsis Biomarkers Market Size Share by Country (2017-2028)

Figure 20. United States Sepsis Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 21. Canada Sepsis Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 22. Europe Sepsis Biomarkers Market Size YoY (2017-2028) & (US$ Million)

Figure 23. Europe Sepsis Biomarkers Market Size Market Share by Type (2017-2028)

Figure 24. Europe Sepsis Biomarkers Market Size Market Share by Application (2017-2028)

Figure 25. Europe Sepsis Biomarkers Market Size Share by Country (2017-2028)

Figure 26. Germany Sepsis Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 27. France Sepsis Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 28. U.K. Sepsis Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 29. Italy Sepsis Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 30. Russia Sepsis Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 31. Nordic Countries Sepsis Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 32. Asia-Pacific Sepsis Biomarkers Market Size YoY (2017-2028) & (US$ Million)

Figure 33. Asia Pacific Sepsis Biomarkers Market Size Market Share by Type (2017-2028)

Figure 34. Asia Pacific Sepsis Biomarkers Market Size Market Share by Application (2017-2028)

Figure 35. Asia Pacific Sepsis Biomarkers Market Size Share by Region (2017-2028)

Figure 36. China Sepsis Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 37. Japan Sepsis Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 38. South Korea Sepsis Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 39. Southeast Asia Sepsis Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 40. India Sepsis Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 41. Australia Sepsis Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)

List of Figures

Figure 42. Latin America Sepsis Biomarkers Market Size YoY (2017-2028) & (US$ Million)

Figure 43. Latin America Sepsis Biomarkers Market Size Market Share by Type (2017-2028)

Figure 44. Latin America Sepsis Biomarkers Market Size Market Share by Application (2017-2028)

Figure 45. Latin America Sepsis Biomarkers Market Size Share by Country (2017-2028)

Figure 46. Mexico Sepsis Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 47. Brazil Sepsis Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 48. Middle East & Africa Sepsis Biomarkers Market Size YoY (2017-2028) & (US$ Million)

Figure 49. Middle East and Africa Sepsis Biomarkers Market Size Market Share by Type (2017-2028)

Figure 50. Middle East and Africa Sepsis Biomarkers Market Size Market Share by Application (2017-2028)

Figure 51. Middle East and Africa Sepsis Biomarkers Market Size Share by Country (2017-2028)

Figure 52. Turkey Sepsis Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 53. Saudi Arabia Sepsis Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 54. UAE Sepsis Biomarkers Market Size YoY Growth (2017-2028) & (US$ Million)

Figure 55. Thermo Fisher Scientific Revenue Growth Rate in Sepsis Biomarkers Business (2017-2022)

Figure 56. Merck Revenue Growth Rate in Sepsis Biomarkers Business (2017-2022)

Figure 57. Bio-Rad Laboratories Revenue Growth Rate in Sepsis Biomarkers Business (2017-2022)

Figure 58. QIAGEN Revenue Growth Rate in Sepsis Biomarkers Business (2017-2022)

Figure 59. Roche Revenue Growth Rate in Sepsis Biomarkers Business (2017-2022)

Figure 60. Danaher Corporation Revenue Growth Rate in Sepsis Biomarkers Business (2017-2022)

Figure 61. Siemens Healthcare Revenue Growth Rate in Sepsis Biomarkers Business (2017-2022)

Figure 62. Abbott Revenue Growth Rate in Sepsis Biomarkers Business (2017-2022)

Figure 63. GenMark Diagnostics Revenue Growth Rate in Sepsis Biomarkers Business (2017-2022)

Figure 64. HiMedia Laboratories Revenue Growth Rate in Sepsis Biomarkers Business (2017-2022)

Figure 65. Immunexpress Revenue Growth Rate in Sepsis Biomarkers Business (2017-2022)

Figure 66. Abionic Revenue Growth Rate in Sepsis Biomarkers Business (2017-2022)

Figure 67. T2 Biosystems Revenue Growth Rate in Sepsis Biomarkers Business (2017-2022)

Figure 68. Bottom-up and Top-down Approaches for This Report

Figure 69. Data Triangulation

Figure 70. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

Global Sepsis Biomarkers Market Insights and Forecast to 2028

Published Date: March 2022

Report Code: QYRE-Auto-15W2051

Global Sepsis Biomarkers Market Insights and Forecast to 2028

FEATURED COMPANIES

Sepsis Biomarkers Market 2028

Sepsis Biomarkers Scope and Market Size

Segment by Type

Segment by Application

BY COMPANY

BY REGION

FEATURED COMPANIES